key: cord-0766760-y62yda9f
authors: Giannattasio, Antonietta; Maglione, Marco; D'Anna, Carolina; Muzzica, Stefania; Angrisani, Francesca; Acierno, Sabrina; Perrella, Alessandro; Tipo, Vincenzo
title: Silent RSV in infants with SARS‑CoV‑2 infection: A case series
date: 2021-05-25
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.25465
sha: 7083e21db22daac616f7244f1a0c49b872a9ac51
doc_id: 766760
cord_uid: y62yda9f

nan

To the Editor, We deeply commend Rotulo et al. 1 Diagnostici; sensitivity > 95%, specificity 100%, accuracy 92%).

Patients' characteristics are reported in Table 1 Findings from a large multicenter study on pediatric SARS-CoV-2 infection seem to support these results, as viral coinfection was reported to be significantly related to a higher risk of intensive care unit (ICU) admission. 5 However, some drawbacks prevent the generalization of these results. First, the presence of coinfections was tested only in onethird of patients, mostly hospitalized, thus a selection bias cannot be excluded. Furthermore, data on specific RSV-SARS-CoV-2 coinfection are not provided, and the authors state that viral coinfections were mostly sustained by rhino/enterovirus. Therefore, of the eight patients who required ICU admission out of 45 with viral coinfection, we do not know how many, if any, had RSV. Finally, unlike viral coinfection, the presence of underlying comorbidities was found to be a risk factor for ICU admission at multivariate analysis, thus suggesting a possible interference of this variable.

Unlike the mentioned studies, our data do not support the hypothesis that the combined RSV-SARS-CoV-2 infection leads to a more severe clinical picture, as our patients only presented mild fever and respiratory symptoms with an uncomplicated evolution.

In addition to the limitations discussed so far, these conflicting data likely derive from the patients included in the available studies. Indeed, RSV is known to be of scarce clinical relevance in adults, but it may cause severe respiratory disease in infants.

Therefore, one could speculate that no worse clinical expression was found in patients with combined RSV and SARS-CoV-2 infection due to the fact that in adults RSV is generally not responsible for significant symptoms. However, unexpectedly, our results confirm that, also in infants, RSV coexistence does not worsen COVID-19 symptoms. A very recent study showed that pathways for overexpressed genes are highly concordant between patients with SARS-CoV-2 and non-SARS-CoV-2 viral infections. 6 We can speculate that, in coinfected patients, increased SARS-CoV-2 viral replication may occur compared to concomitant other viruses, due to the characteristics of infectivity and replication of SARS-CoV-2.

As COVID-19 in children is a mild disease in the majority of cases, 7 it is possible to hypothesize that, in coinfected children, SARS-CoV-2 overbears RSV, inhibiting its replication and thus its clinical expression.

As for the accuracy of the RSV diagnostic test used in our study, no cross-reaction with other respiratory antigens as influenza A and B or adenovirus has been reported. 8 

The authors declare that there are no conflict of interests.

infants, outcome, respiratory syncytial virus, SARS-CoV-2 T A B L E 1 Characteristics of 6 infants with SARS-CoV-2 and RSV coinfection Note: CRP (n.v. < 5 mg/L); PCT (n.v. < 0.5 ng/ml); ferritin: n.v. < 320 ng/ml.

Abbreviations: CRP, C-reactive protein; F, female; M, male; PCT, procalcitonin; RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

LETTER TO THE EDITOR

Unexpected peak of bronchiolitis requiring oxygen therapy in February 2020: could an undetected SARS-CoV2-RSV coinfection be the cause?

COVID-19 related reduction in pediatric emergency healthcare utilization-a concerning trend

Coinfection of SARS-CoV-2 and other respiratory pathogens

Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children

Epidemiology, clinical features and prognostic factors of pediatric sars-cov-2 infection: results from an Italian multicenter study

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections. iScience

Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10

Clinical and financial benefits of rapid detection of respiratory viruses: an outcomes study